2023Research article
Phytochemical, GC-MS, FTIR and Amino acid profile of methanol extract of Tetrapleura tetraptera fruit.
Journal of Drug Delivery and Therapeutics
18+ citationsView details
Publications & Research Portfolio
Research portfolio
Peer-reviewed founder publications, collaborative manuscripts under review, and active CLINX research programmes.
01 · Founder Publications
Founder publications
Peer-reviewed publications authored by the founder before the establishment of CLINX Research & Biosciences.
Lead Author (2) · Co-author (2)
2023Research article
GCMS and FTIR analysis of ethanol and methanol leave extract of Urena lobata (Caesar weed) for bioactive phytochemical constituents
Journal of Drug Delivery and Therapeutics
31+ citationsView details
2022Research article
Renal function parameters and hematological indices among artisans occupationally exposed to Lead in Suleja metropolis, Nigeria.
Research Journal in Medical and Health Sciences
2+ citationsView details
2023Research article
Phytochemical and nutritional composition of ethanol-water leaf extracts of Justicia secunda and Jatropha tanjorensis.
GSC Biological and Pharmaceutical Sciences
6+ citationsView details
02 · Collaborative Research Under Review
Collaborative research under review
Manuscripts co-authored with research partners, currently undergoing international peer review.
Under peer reviewCo-author (6th Author)
Multiscale Computational Modelling of Host-Pathogen Immune Dynamics
Journal: Journal of Molecular Modeling
Under peer reviewCo-author (6th Author)
Stimuli-Response Nanotherapeutic Strategies for Metabolic Disease Research.
Journal: In Silico Pharmacology (Springer)
03 · CLINX Research Programmes
Current CLINX research programmes
Founder-designed research conducted under CLINX Research & Biosciences.
4 active programmes
Programme 1Active research programme
Natural Product Discovery for Metabolic Disease Targets
Experimental Biochemistry. Computational Bioscience. Molecular Docking.
Experimental and computational investigation of naturally occurring bioactive compounds for enzyme targets associated with metabolic disorders. Detailed methodologies and findings will be disclosed following publication.
Programme 2Active research programme
Comparative Antioxidant and Safety Evaluation of Therapeutic Natural Product
Biochemistry. Toxicology. Natural Product Research.
Comparative evaluation of antioxidant capacity and preliminary safety profiles of selected medicinal plant candidates to support evidence-based natural product research.
Programme 3Active research programme
Structure-Based Investigation of Opioid Receptor Interactions
Structural Biology. Molecular Dynamics. Computational Pharmacology.
Applying molecular dynamics simulations and structural modelling to investigate receptor-ligand interaction networks relevant to pain pharmacology.
Programme 4Active research programme
Virtual Screening of Brain-Penetrant Natural Product Candidates
Virtual Screening. ADMET Prediction. Molecular Docking.
Screening naturally derived compounds using computational approaches to identify candidates with favourable predicted central nervous system properties.